Argonne National Laboratory

Virtual lecture series finale connects interns to ongoing COVID-19 research

29-Jul-2020 6:55 PM EDT, by Argonne National Laboratory

Newswise — As a final milestone in their summer internships, students participating in the 2020 Office of Science Summer Internship Virtual Lecture Series attended a final seminar on July 22, 2020 that demonstrated how the Department of Energy’s (DOE) National Laboratories are researching COVID-19 and connecting students to the labs’ vibrant science, technology, engineering and mathematics (STEM) communities.

Between June and July 2020, the DOE Office of Science, in collaboration with 17 DOE National Laboratories, hosted a series of virtual seminars to help enrich students’ summer experiences at the laboratories. The lecture series was open to any students who had summer appointments at any of the 17 national labs, with over 5,000 different students invited to participate. Each session covered a different component of the DOE and national labs’ operations, from DOE science and technology endeavors to a panel led by graduate STEM students. The seminar on July 22 was especially timely and impactful, as it addressed DOE’s response to COVID-19.

“NVBL represents the DOE’s continued determination to find solutions to urgent challenges around the world, using some of the most advanced scientific facilities and professionals this country has to offer. Though this challenge is unprecedented, every one of us makes a difference, as we work together to tackle COVID-19.” — Dr. Chris Fall, director of the Office of Science

At the virtual lecture on July 22, scientists in the panel told students how the National Virtual Biotechnology Laboratory (NVBL) is addressing key issues related to the pandemic. The NVBL, a consortium of DOE National Laboratories focused on response to COVID-19, with funding provided by the Coronavirus CARES Act, combines the efforts of all 17 national laboratories.

“NVBL represents the DOE’s continued determination to find solutions to urgent challenges around the world, using some of the most advanced scientific facilities and professionals this country has to offer. Though this challenge is unprecedented, every one of us makes a difference, as we work together to tackle COVID-19,” said Dr. Chris Fall, director of the Office of Science.

Martha Head, director of the Joint Institute for Biological Sciences at Oak Ridge National Laboratory, shared with the students her work on the NVBL’s Molecular Design for Medical Therapeutics project. This project applies supercomputers, nanoscience and other national lab resources to develop therapeutic treatment for COVID-19. Joseph “Pat” Fitch, associate laboratory director for Los Alamos National Laboratory, is working on NVBL’s COVID-19 Testing R&D project to create better diagnostic tests for the virus.

NVBL is also fixing indirect problems stemming from COVID-19. As discussed by Oak Ridge’s Manufacturing Systems Research group leader Lonnie Love during the panel, the NVBL’s Manufacturing project works to improve the supply chain response to COVID-19 with more efficient production and distribution of face masks, ventilators and other essential equipment. Already, Lawrence Livermore National Laboratory has helped the NVBL test new 3D-printed nasopharyngeal swabs.

“I find it wonderful that our interns had a front-row seat to the groundbreaking work we’re undertaking against COVID-19,” said Stephen Streiffer, deputy laboratory director for science and technology for Argonne National Laboratory and co-leader for NVBL. “Unique, first-hand experiences like this pave the way for the next generation of STEM leaders, who will continue to develop scientific solutions for grand challenges worldwide.”

This work was supported in part by the U.S. Department of Energy, Office of Science.

Argonne National Laboratory seeks solutions to pressing national problems in science and technology. The nation’s first national laboratory, Argonne conducts leading-edge basic and applied scientific research in virtually every scientific discipline. Argonne researchers work closely with researchers from hundreds of companies, universities, and federal, state and municipal agencies to help them solve their specific problems, advance America’s scientific leadership and prepare the nation for a better future. With employees from more than 60 nations, Argonne is managed by UChicago Argonne, LLC for the U.S. Department of Energy’s Office of Science.

The U.S. Department of Energy’s Office of Science is the single largest supporter of basic research in the physical sciences in the United States and is working to address some of the most pressing challenges of our time. For more information, visit https://energy.gov/science.




Filters close

Showing results

110 of 4146
Newswise: Long-Term Impacts of COVID-19: Your Mental Health
Released: 25-Nov-2020 2:15 PM EST
Long-Term Impacts of COVID-19: Your Mental Health
Cedars-Sinai

The COVID-19 pandemic has shaped more than half a year of our lives, canceling plans, upending livelihoods and causing feelings of grief, stress and anxiety. And Cedars-Sinai mental health experts say the pandemic could be shaping our mental health well into the future.

Released: 25-Nov-2020 12:45 PM EST
SARS-CoV-2 mutations do not appear to increase transmissibility
University College London

None of the mutations currently documented in the SARS-CoV-2 virus appear to increase its transmissibility in humans, according to a study led by UCL researchers.

Newswise: COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
Released: 25-Nov-2020 11:05 AM EST
COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
University of Alabama at Birmingham

Maryland-based Altimmune Inc., a clinical stage biopharmaceutical company, has submitted an Investigational New Drug, or IND, application to the United States Food and Drug Administration to commence a Phase 1 clinical study of its single-dose intranasal COVID-19 vaccine candidate, AdCOVID.

Released: 25-Nov-2020 11:05 AM EST
BIDMC researchers reveal how genetic variations are linked to COVID-19 disease severity
Beth Israel Lahey Health

New research BIDMC-led sheds light on the genetic risk factors that make individuals more or less susceptible to severe COVID-19.

Newswise: blog-pandemic-scenario-planning-lg-feature2.jpg
Released: 25-Nov-2020 11:05 AM EST
Pandemic Ups Game on Scenario Planning in The Arts
Wallace Foundation

Researcher/Author of new toolkit and report seeks to help arts and culture organizations add scenario planning to their strategic toolbox

Released: 25-Nov-2020 10:30 AM EST
Young people's anxiety levels doubled during first COVID-19 lockdown, says study
University of Bristol

The number of young people with anxiety doubled from 13 per cent to 24 per cent, during the early stages of the COVID-19 pandemic and lockdown 1, according to new research from the University of Bristol.

Newswise: 249837_web.jpg
Released: 25-Nov-2020 10:20 AM EST
Tracking COVID-19 trends in hard-hit states
Louisiana State University

Currently, there are over 10 million confirmed cases and more than 240,000 casualties attributed to COVID-19 in the U.S.

Released: 25-Nov-2020 9:55 AM EST
More Health Systems Join National #MaskUp Campaign
Cleveland Clinic

Many more health systems are joining the national #MaskUp campaign encouraging Americans to stop the spread of COVID-19 by following safety guidelines. Over just a few days, another 19 health systems with hundreds of hospitals united with 100 health systems nationwide with hospitals numbering in the thousands. The public service campaign is critical to the health and well-being of all Americans. It is a plea from healthcare professionals everywhere: wear a mask and follow other precautions to save lives and help get our country back on its feet.

Newswise: delaterre_jpeg.jpg
Released: 25-Nov-2020 7:35 AM EST
Warwick scientists design model to predict cellular drug targets against Covid-19
University of Warwick

The covid-19 virus, like all viruses relies on their host for reproduction

access_time Embargo lifts in 2 days
Embargo will expire: 30-Nov-2020 10:00 AM EST Released to reporters: 24-Nov-2020 5:35 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 30-Nov-2020 10:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

110 of 4146

close
0.96178